Changeflow GovPing Healthcare & Life Sciences Patent Application US20260085058A1 for SOS1 Deg...
Routine Notice Added Draft

Patent Application US20260085058A1 for SOS1 Degraders Treating Cancers

Favicon for changeflow.com USPTO Patent Applications - Organic Chemistry (C07D)
Published
Detected
Email

Summary

The USPTO has published patent application US20260085058A1, which relates to compounds that degrade son of sevenless homolog 1 (SOS1) and their use in treating cancers, particularly KRAS-mutant cancers. The application was filed on August 11, 2023.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

This document is a publication of a patent application (US20260085058A1) filed with the USPTO on August 11, 2023. The application discloses compounds designed to degrade the SOS1 protein, with a stated use in treating various cancers, specifically those with KRAS mutations. The inventors listed are Yu YUAN and Hao XIE.

As this is a patent application, it does not impose immediate regulatory obligations or compliance deadlines on entities. However, it signals potential future developments in cancer therapeutics and may be of interest to pharmaceutical companies and researchers in the oncology space. The application is classified under CPC codes including C07D 401/14, A61K 31/517, A61P 35/00, and C07D 417/14.

Archived snapshot

Mar 26, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

DEGRADERS OF SON OF SEVENLESS HOMOLOG 1

Application US20260085058A1 Kind: A1 Mar 26, 2026

Inventors

Yu YUAN, Hao XIE

Abstract

This disclosure relates to compounds which are degraders of son of sevenless homolog 1 (SOS1) and their use in treating cancers, in particular KRAS-mutant cancers.

CPC Classifications

C07D 401/14 A61K 31/517 A61P 35/00 C07D 417/14

Filing Date

2023-08-11

Application No.

19103367

View original document →

Named provisions

DEGRADERS OF SON OF SEVENLESS HOMOLOG 1

Get daily alerts for USPTO Patent Applications - Organic Chemistry (C07D)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
August 11th, 2023
Instrument
Notice
Legal weight
Non-binding
Stage
Draft
Change scope
Minor
Document ID
US20260085058A1

Who this affects

Applies to
Drug manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Drug Development
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Compliance frameworks
FDA 21 CFR Part 11 GxP
Topics
Drug Development Oncology

Get alerts for this source

We'll email you when USPTO Patent Applications - Organic Chemistry (C07D) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!